Papers: 25 Jul 2014 - 1 Aug 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Is it time for a new global classification of multiple sclerosis? Melcon MO, Correale J, Melcon CM J Neurol Sci. 2014 Jun 29. Epub 1969 Dec 31. PMID: 25062946. Abstract Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis. Salbach N M, Howe J A, Brunton K, Salisbury K, Bodiam L J Phys Act Health. 2014 May; 11(4):838-45. PMID: 25078526. Abstract Decision-making impairment in patients with multiple sclerosis: a case-control study. Farez MF, Crivelli L, Leiguarda R, Correale J BMJ Open. 2014; 4(7):e004918. PMID: 25079923. Abstract Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy. Vennegoor A, Rispens T, Van Oosten B, Wattjes MP, Wondergem M, Teunissen CE, Van der Kleij D, Uitdehaag BMJ, Polman CH, Killestein J Mult Scler. 2014 Jul 30. PMID: 25078275. Abstract Navigating Life and Loss in Pediatric Multiple Sclerosis. Thannhauser JE Qual Health Res. 2014 Jul 30. PMID: 25079499. Abstract Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling. Luo FC, Burke K, Kantor C, Miller RH, Yang Y J Neurosci. 2014 Jul 30; 34(31):10415-29. PMID: 25080600. Abstract Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury. Rodriguez JP, Coulter M, Miotke J, Meyer RL, Takemaru K-I, Levine JM J Neurosci. 2014 Jul 30; 34(31):10285-97. PMID: 25080590. Abstract Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor. Figueiredo CA, Drohomyrecky PC, McCarthy SDS, Leontyev D, Ma X-Z, Branch DR, Dunn SE PLoS One. 2014; 9(7):e101947. Epub 2014 Jul 31. PMID: 25078447. Abstract Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3. Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S-ichiro, Suzuki K, Takatori H, Tamachi T, Hirose K, Onodera A, et al. J Exp Med. 2014 Jul 29. PMID: 25073789. Abstract [Oculomotor system and multiple sclerosis.] Höh AE, Beisse C Ophthalmologe. 2014 Jul 31. PMID: 25074654. Abstract JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection. Maginnis MS, Nelson CDS, Atwood WJ J Neurovirol. 2014 Jul 31. Epub 2014 Jul 31. PMID: 25078361. Abstract Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. Kurnellas MP, Schartner JM, Fathman GC, Jagger A, Steinman L, Rothbard JB J Exp Med. 2014 Jul 29. PMID: 25073790. Abstract Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Kezuka T, Tanaka K, Matsunaga Y, Sato DK, Takahashi T, Waters PJ, Fujihara K Neurology. 2014 Jul 29; 83(5):475-6. PMID: 25074893. Abstract Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells. Liu G, Guo J, Liu J, Wang Z, Liang D Clin Immunol. 2014 Jul 27; 154(2):127-140. PMID: 25076485. Abstract Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. Cramer SP, Larsson HBW J Cereb Blood Flow Metab. 2014 Jul 30. PMID: 25074746. Abstract Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Seddighzadeh A, Hung S, Selmaj K, Cui Y, Liu S, Sperling B, Calabresi PA Expert Opin Drug Deliv. 2014 Jul 29:1-8. PMID: 25073663. Abstract Novel characterization of gait impairments in people with multiple sclerosis by means of the gait profile score. Pau M, Coghe G, Atzeni C, Corona F, Pilloni G, Marrosu M G, Cocco E, Galli M J Neurol Sci. 2014 Jul 19. PMID: 25073571. Abstract Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. Kivisäkk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ PLoS One. 2014; 9(7):e103716. Epub 2014 Jul 30. PMID: 25075741. Abstract A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T. Gratsias G, Kapsalaki E, Kogia S, Dardiotis E, Tsimourtou V, Lavdas E, Kousi E, Pelekanou A, Hadjigeorgiou GM, Fezoulidis I Acta Neurol Belg. 2014 Jul 30. Epub 2014 Jul 30. PMID: 25073775. Abstract Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Paraboschi EM, Rimoldi V, Soldà G, Tabaglio T, Dall'Osso C, Saba E, Vigliano M, Salviati A, Leone M, Benedetti MD, et al. Hum Mol Genet. 2014 Jul 30. Epub 2014 Jul 30. PMID: 25080502. Abstract The role of antiproliferative gene Tob1 in the immune system. Baranzini SE Clin Exp Neuroimmunol. 2014 Jun 1; 5(2):132-136. PMID: 25071870. Abstract Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction. Heneka MT J Exp Med. 2014 Jul 28; 211(8):1500. PMID: 25071159. Abstract Pain in neuromyelitis optica-prevalence, pathogenesis and therapy. Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandkühler J Nat Rev Neurol. 2014 Jul 29. PMID: 25072195. Abstract Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B J Neuroinflammation. 2014; 11(1):129. Epub 2014 Jul 29. PMID: 25074611. Abstract Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord. Heiman A, Pallottie A, Heary RF, Elkabes S Brain Behav Immun. 2014 Jul 22. PMID: 25063708. Abstract Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2. Ji Z, Fan Z, Zhang Y, Yu R, Yang H, Zhou C, Luo J, Ke Z-J J Immunol. 2014 Jul 25. PMID: 25063874. Abstract Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis. Sanford M Drugs. 2014 Jul 26. PMID: 25063048. Abstract [New aspects in the therapy of multiple sclerosis and optic neuritis.] Lagrèze W, Diem R Ophthalmologe. 2014 Jul 27. PMID: 25063544. Abstract Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A Cochrane Database Syst Rev. 2014; 7:CD009333. Epub 1969 Dec 31. PMID: 25062935. Abstract Aquatherapy for neurodegenerative disorders. Plecash AR, Leavitt BR J Huntingtons Dis. 2014 Jan; 3(1):5-11. PMID: 25062761. Abstract Value, challenges, and satisfaction of certification for multiple sclerosis specialists. Gulick EE, Halper J Int J MS Care. 2014 Summer; 16(2):83-90. PMID: 25061432. Abstract An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions. Pattee GL, Wymer JP, Lomen-Hoerth C, Appel SH, Formella AE, Pope LE Curr Med Res Opin. 2014 Jul 28:1-11. PMID: 25062507. Abstract Short-term effect of aerobic exercise on symptoms in multiple sclerosis and chronic fatigue syndrome: a pilot study. Learmonth YC, Paul L, McFadyen AK, Marshall-McKenna R, Mattison P, Miller L, McFarlane NG Int J MS Care. 2014 Summer; 16(2):76-82. PMID: 25061431. Abstract OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury. Sanford M Drugs. 2014 Jul 25. PMID: 25060982. Abstract Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. Dai JX, Bercury KK, Macklin WB Glia. 2014 Jul 25. PMID: 25060812. Abstract Validation of mood measures for people with multiple sclerosis. Watson TM, Ford E, Worthington E, Lincoln NB Int J MS Care. 2014 Summer; 16(2):105-9. PMID: 25061435. Abstract Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle. Ratchford JN, Brock-Simmons R, Augsburger A, Steele SU, Mohn K, Rhone M, Bo J, Costello K Int J MS Care. 2014 Summer; 16(2):92-8. PMID: 25061433. Abstract Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis. Kozma CM, Phillips AL, Meletiche DM J Manag Care Pharm. 2014 Aug; 20(8):800-7. PMID: 25062073. Abstract Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis. Franklin MA, Happe LE, Dillman R, Marshall LZ J Manag Care Pharm. 2014 Aug; 20(8):795-9. PMID: 25062072. Abstract Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review. Asano M, Raszewski R, Finlayson M Int J MS Care. 2014 Summer; 16(2):99-104. PMID: 25061434. Abstract Treatment satisfaction in multiple sclerosis. Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC Int J MS Care. 2014 Summer; 16(2):68-75. PMID: 25061430. Abstract The multiple sclerosis self-management scale: clinicometric testing. Ghahari S, Khoshbin LS, Forwell SJ Int J MS Care. 2014 Summer; 16(2):61-7. PMID: 25061429. Abstract Microglia as a critical player in both developmental and late-life CNS pathologies. Derecki NC, Katzmarski N, Kipnis J, Meyer-Luehmann M Acta Neuropathol. 2014 Jul 24. PMID: 25056803. Abstract Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLOS ONE Staff PLoS One. 2014; 9(7):e103890. Epub 2014 Jul 25. PMID: 25061752. Abstract Recent advances and future challenges in the genetics of multiple sclerosis. Lill CM Front Neurol. 2014; 5:130. Epub 2014 Jul 14. PMID: 25071715. Abstract The potential of epigenetic therapies in neurodegenerative diseases. Coppedè F Front Genet. 2014; 5:220. Epub 2014 Jul 14. PMID: 25071843. Abstract The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue? Cicchetti F, Barker RA Front Pharmacol. 2014; 5:139. Epub 2014 Jul 10. PMID: 25071571. Abstract Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Koudriavtseva T Front Neurol. 2014; 5:119. Epub 2014 Jul 07. PMID: 25071707. Abstract Chemokine receptor expression by inflammatory T cells in EAE. Mony J T, Khorooshi R, Owens T Front Cell Neurosci. 2014; 8:187. Epub 2014 Jul 04. PMID: 25071447. Abstract Vitamin D in inflammatory diseases. Wöbke TK, Sorg BL, Steinhilber D Front Physiol. 2014; 5:244. Epub 2014 Jul 02. PMID: 25071589. Abstract Type I interferon in human autoimmunity. Niewold TB Front Immunol. 2014; 5:306. Epub 2014 Jun 30. PMID: 25071767. Abstract Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect. Schoedel KA, Morrow SA, Sellers EM Neuropsychiatr Dis Treat. 2014; 10:1161-74. Epub 2014 Jun 26. PMID: 25061302. Abstract Analysis of macular OCT images using deformable registration. Chen M, Lang A, Ying HS, Calabresi PA, Prince JL, Carass A Biomed Opt Express. 2014 Jul 1; 5(7):2196-214. Epub 2014 Jun 11. PMID: 25071959. Abstract Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. Sertbaş M, Ulgen K, Cakır T FEBS Open Bio. 2014; 4:542-53. Epub 2014 Jun 06. PMID: 25061554. Abstract Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them? Dillon BE, Lemack GE Urol Clin North Am. 2014 Aug; 41(3):439-444. Epub 2014 May 20. PMID: 25063600. Abstract Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report. He D, Yu YL, Yan WB, Dai QQ, Xu Z, Chu L Pediatr Neurol. 2014 Aug; 51(2):255-8. Epub 2014 Jan 24. PMID: 25079575. Abstract
Editors' Pick Is it time for a new global classification of multiple sclerosis? Melcon MO, Correale J, Melcon CM J Neurol Sci. 2014 Jun 29. Epub 1969 Dec 31. PMID: 25062946. Abstract
Partnering to increase access to community exercise programs for people with stroke, acquired brain injury, and multiple sclerosis. Salbach N M, Howe J A, Brunton K, Salisbury K, Bodiam L J Phys Act Health. 2014 May; 11(4):838-45. PMID: 25078526. Abstract
Decision-making impairment in patients with multiple sclerosis: a case-control study. Farez MF, Crivelli L, Leiguarda R, Correale J BMJ Open. 2014; 4(7):e004918. PMID: 25079923. Abstract
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy. Vennegoor A, Rispens T, Van Oosten B, Wattjes MP, Wondergem M, Teunissen CE, Van der Kleij D, Uitdehaag BMJ, Polman CH, Killestein J Mult Scler. 2014 Jul 30. PMID: 25078275. Abstract
Navigating Life and Loss in Pediatric Multiple Sclerosis. Thannhauser JE Qual Health Res. 2014 Jul 30. PMID: 25079499. Abstract
Cyclin-Dependent Kinase 5 Mediates Adult OPC Maturation and Myelin Repair through Modulation of Akt and GsK-3β Signaling. Luo FC, Burke K, Kantor C, Miller RH, Yang Y J Neurosci. 2014 Jul 30; 34(31):10415-29. PMID: 25080600. Abstract
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury. Rodriguez JP, Coulter M, Miotke J, Meyer RL, Takemaru K-I, Levine JM J Neurosci. 2014 Jul 30; 34(31):10285-97. PMID: 25080590. Abstract
Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor. Figueiredo CA, Drohomyrecky PC, McCarthy SDS, Leontyev D, Ma X-Z, Branch DR, Dunn SE PLoS One. 2014; 9(7):e101947. Epub 2014 Jul 31. PMID: 25078447. Abstract
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3. Tanaka S, Suto A, Iwamoto T, Kashiwakuma D, Kagami S-ichiro, Suzuki K, Takatori H, Tamachi T, Hirose K, Onodera A, et al. J Exp Med. 2014 Jul 29. PMID: 25073789. Abstract
[Oculomotor system and multiple sclerosis.] Höh AE, Beisse C Ophthalmologe. 2014 Jul 31. PMID: 25074654. Abstract
JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection. Maginnis MS, Nelson CDS, Atwood WJ J Neurovirol. 2014 Jul 31. Epub 2014 Jul 31. PMID: 25078361. Abstract
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease. Kurnellas MP, Schartner JM, Fathman GC, Jagger A, Steinman L, Rothbard JB J Exp Med. 2014 Jul 29. PMID: 25073790. Abstract
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Kezuka T, Tanaka K, Matsunaga Y, Sato DK, Takahashi T, Waters PJ, Fujihara K Neurology. 2014 Jul 29; 83(5):475-6. PMID: 25074893. Abstract
Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells. Liu G, Guo J, Liu J, Wang Z, Liang D Clin Immunol. 2014 Jul 27; 154(2):127-140. PMID: 25076485. Abstract
Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients. Cramer SP, Larsson HBW J Cereb Blood Flow Metab. 2014 Jul 30. PMID: 25074746. Abstract
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Seddighzadeh A, Hung S, Selmaj K, Cui Y, Liu S, Sperling B, Calabresi PA Expert Opin Drug Deliv. 2014 Jul 29:1-8. PMID: 25073663. Abstract
Novel characterization of gait impairments in people with multiple sclerosis by means of the gait profile score. Pau M, Coghe G, Atzeni C, Corona F, Pilloni G, Marrosu M G, Cocco E, Galli M J Neurol Sci. 2014 Jul 19. PMID: 25073571. Abstract
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. Kivisäkk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ PLoS One. 2014; 9(7):e103716. Epub 2014 Jul 30. PMID: 25075741. Abstract
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T. Gratsias G, Kapsalaki E, Kogia S, Dardiotis E, Tsimourtou V, Lavdas E, Kousi E, Pelekanou A, Hadjigeorgiou GM, Fezoulidis I Acta Neurol Belg. 2014 Jul 30. Epub 2014 Jul 30. PMID: 25073775. Abstract
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Paraboschi EM, Rimoldi V, Soldà G, Tabaglio T, Dall'Osso C, Saba E, Vigliano M, Salviati A, Leone M, Benedetti MD, et al. Hum Mol Genet. 2014 Jul 30. Epub 2014 Jul 30. PMID: 25080502. Abstract
The role of antiproliferative gene Tob1 in the immune system. Baranzini SE Clin Exp Neuroimmunol. 2014 Jun 1; 5(2):132-136. PMID: 25071870. Abstract
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction. Heneka MT J Exp Med. 2014 Jul 28; 211(8):1500. PMID: 25071159. Abstract
Pain in neuromyelitis optica-prevalence, pathogenesis and therapy. Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, Sandkühler J Nat Rev Neurol. 2014 Jul 29. PMID: 25072195. Abstract
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate. Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B J Neuroinflammation. 2014; 11(1):129. Epub 2014 Jul 29. PMID: 25074611. Abstract
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord. Heiman A, Pallottie A, Heary RF, Elkabes S Brain Behav Immun. 2014 Jul 22. PMID: 25063708. Abstract
Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2. Ji Z, Fan Z, Zhang Y, Yu R, Yang H, Zhou C, Luo J, Ke Z-J J Immunol. 2014 Jul 25. PMID: 25063874. Abstract
Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis. Sanford M Drugs. 2014 Jul 26. PMID: 25063048. Abstract
[New aspects in the therapy of multiple sclerosis and optic neuritis.] Lagrèze W, Diem R Ophthalmologe. 2014 Jul 27. PMID: 25063544. Abstract
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis. La Mantia L, Di Pietrantonj C, Rovaris M, Rigon G, Frau S, Berardo F, Gandini A, Longobardi A, Weinstock-Guttman B, Vaona A Cochrane Database Syst Rev. 2014; 7:CD009333. Epub 1969 Dec 31. PMID: 25062935. Abstract
Aquatherapy for neurodegenerative disorders. Plecash AR, Leavitt BR J Huntingtons Dis. 2014 Jan; 3(1):5-11. PMID: 25062761. Abstract
Value, challenges, and satisfaction of certification for multiple sclerosis specialists. Gulick EE, Halper J Int J MS Care. 2014 Summer; 16(2):83-90. PMID: 25061432. Abstract
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions. Pattee GL, Wymer JP, Lomen-Hoerth C, Appel SH, Formella AE, Pope LE Curr Med Res Opin. 2014 Jul 28:1-11. PMID: 25062507. Abstract
Short-term effect of aerobic exercise on symptoms in multiple sclerosis and chronic fatigue syndrome: a pilot study. Learmonth YC, Paul L, McFadyen AK, Marshall-McKenna R, Mattison P, Miller L, McFarlane NG Int J MS Care. 2014 Summer; 16(2):76-82. PMID: 25061431. Abstract
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury. Sanford M Drugs. 2014 Jul 25. PMID: 25060982. Abstract
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation. Dai JX, Bercury KK, Macklin WB Glia. 2014 Jul 25. PMID: 25060812. Abstract
Validation of mood measures for people with multiple sclerosis. Watson TM, Ford E, Worthington E, Lincoln NB Int J MS Care. 2014 Summer; 16(2):105-9. PMID: 25061435. Abstract
Multiple sclerosis symptom recrudescence at the end of the natalizumab dosing cycle. Ratchford JN, Brock-Simmons R, Augsburger A, Steele SU, Mohn K, Rhone M, Bo J, Costello K Int J MS Care. 2014 Summer; 16(2):92-8. PMID: 25061433. Abstract
Use of an early disease-modifying drug adherence measure to predict future adherence in patients with multiple sclerosis. Kozma CM, Phillips AL, Meletiche DM J Manag Care Pharm. 2014 Aug; 20(8):800-7. PMID: 25062073. Abstract
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis. Franklin MA, Happe LE, Dillman R, Marshall LZ J Manag Care Pharm. 2014 Aug; 20(8):795-9. PMID: 25062072. Abstract
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review. Asano M, Raszewski R, Finlayson M Int J MS Care. 2014 Summer; 16(2):99-104. PMID: 25061434. Abstract
Treatment satisfaction in multiple sclerosis. Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC Int J MS Care. 2014 Summer; 16(2):68-75. PMID: 25061430. Abstract
The multiple sclerosis self-management scale: clinicometric testing. Ghahari S, Khoshbin LS, Forwell SJ Int J MS Care. 2014 Summer; 16(2):61-7. PMID: 25061429. Abstract
Microglia as a critical player in both developmental and late-life CNS pathologies. Derecki NC, Katzmarski N, Kipnis J, Meyer-Luehmann M Acta Neuropathol. 2014 Jul 24. PMID: 25056803. Abstract
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLOS ONE Staff PLoS One. 2014; 9(7):e103890. Epub 2014 Jul 25. PMID: 25061752. Abstract
Recent advances and future challenges in the genetics of multiple sclerosis. Lill CM Front Neurol. 2014; 5:130. Epub 2014 Jul 14. PMID: 25071715. Abstract
The potential of epigenetic therapies in neurodegenerative diseases. Coppedè F Front Genet. 2014; 5:220. Epub 2014 Jul 14. PMID: 25071843. Abstract
The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue? Cicchetti F, Barker RA Front Pharmacol. 2014; 5:139. Epub 2014 Jul 10. PMID: 25071571. Abstract
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Koudriavtseva T Front Neurol. 2014; 5:119. Epub 2014 Jul 07. PMID: 25071707. Abstract
Chemokine receptor expression by inflammatory T cells in EAE. Mony J T, Khorooshi R, Owens T Front Cell Neurosci. 2014; 8:187. Epub 2014 Jul 04. PMID: 25071447. Abstract
Vitamin D in inflammatory diseases. Wöbke TK, Sorg BL, Steinhilber D Front Physiol. 2014; 5:244. Epub 2014 Jul 02. PMID: 25071589. Abstract
Type I interferon in human autoimmunity. Niewold TB Front Immunol. 2014; 5:306. Epub 2014 Jun 30. PMID: 25071767. Abstract
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect. Schoedel KA, Morrow SA, Sellers EM Neuropsychiatr Dis Treat. 2014; 10:1161-74. Epub 2014 Jun 26. PMID: 25061302. Abstract
Analysis of macular OCT images using deformable registration. Chen M, Lang A, Ying HS, Calabresi PA, Prince JL, Carass A Biomed Opt Express. 2014 Jul 1; 5(7):2196-214. Epub 2014 Jun 11. PMID: 25071959. Abstract
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. Sertbaş M, Ulgen K, Cakır T FEBS Open Bio. 2014; 4:542-53. Epub 2014 Jun 06. PMID: 25061554. Abstract
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them? Dillon BE, Lemack GE Urol Clin North Am. 2014 Aug; 41(3):439-444. Epub 2014 May 20. PMID: 25063600. Abstract
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report. He D, Yu YL, Yan WB, Dai QQ, Xu Z, Chu L Pediatr Neurol. 2014 Aug; 51(2):255-8. Epub 2014 Jan 24. PMID: 25079575. Abstract